TokenPost topic

Trevi Therapeutics

1 TokenPost story is tagged Trevi Therapeutics. The newest appear first.

Latest Trevi Therapeutics stories

• Trevi Expects Q1 2027 Start for Phase 2 Non-IPF ILD-Related Chronic Cough Trial

  Trevi’s $299.4 million in cash, cash equivalents and marketable securities is expected to support key programs into 2030.

  Nov 10, 2026, 9:28 PM EST · Business